Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. - Wikidata - awgldk - TriplyDB

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

http://www.wikidata.org/entity/Q34356168

about

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.The epidemiology of venous thromboembolism The association of smoking with venous thrombosis in women. A population-based, case-control study Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study Systematic identification of trans eQTLs as putative drivers of known disease associations ABO genotype and risk of thrombotic events and hemorrhagic stroke.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.The epidemiology of venous thromboembolism in the community.Diabetes mellitus, glycemic control, and risk of atrial fibrillation.A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.Prevention and treatment of venous thromboembolism during HRT: current perspectives.Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study.Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Formulations of hormone therapy and risk of Parkinson's disease.Delivery systems for hormone replacement therapy.Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis.Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.Vascular effects of estrogenic menopausal hormone therapy.Menopausal hormone therapy and venous thromboembolism.The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis.Venous thromboembolism: disease burden, outcomes and risk factors.Breast cancer recurrence risk in relation to antidepressant use after diagnosis.Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study.Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen.Breast cancer recurrence in relation to antidepressant use.Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women.Venous thromboembolism in women.Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials Hormone therapies and venous thromboembolism: where are we now?Menopausal hormone therapy: examining cardiovascular and clinical impacts of treatment.Oral Contraceptives and HRT Risk of Thrombosis.The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women.Hormone replacement treatment choices in complete androgen insensitivity syndrome: an audit of an adult clinic Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.Epidemiology of venous thromboembolism.The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.

P2860

Q24658109-6EE18400-197D-47FE-8F63-1149010E1797 Q28067893-3E67F7E3-D9E3-4B89-A476-40959C50AFAD Q28606831-C7941C69-7FEF-408B-9E7D-3BE137CF948F Q28607716-58D5A158-82E0-4645-9E43-52FFB12F3E29 Q28652242-752172B0-DFAF-4B02-9A58-6DC914A15E8E Q28652245-1834ADE2-6007-4E7B-AEEC-452458A6468E Q28659854-390B7D5C-04F6-4953-86BB-1E920A149FEA Q30496759-7509E754-4F1D-4767-9566-5EC3A52B8A22 Q30659580-B73787FD-FE56-419C-9A29-D39F84B6DE63 Q33865646-30AA22E6-034B-408D-A634-25D807E505E0 Q33959715-5C8CF84C-5B0D-4C33-A95B-999F5E558A7B Q34133879-1F2C8F97-5A57-4E80-A33D-332E050FCC0B Q34140721-A922DCEA-4CFD-4E18-B862-E702786FD5EE Q34288033-69604AA0-917E-4C64-B4BC-202C2807BD9B Q34375771-7498B900-4CCB-432F-9EF5-D57E7D70F20C Q34437648-6562BA41-26D1-4217-954A-39028C028C87 Q34498227-BB272DFC-6243-476D-9858-003CCE4E8D03 Q35037432-8611C8F6-BB7F-42EA-B677-3F295D55212B Q35166781-37B2733A-19D4-4FA7-A1A0-1CAFB5742C78 Q35583311-A6EC4F97-0C65-4431-A191-BE27FFD5E909 Q35903637-4643248C-14F5-4E64-B840-6E74594407BB Q36188259-8452D1E1-8514-454E-916A-0E42D12746A4 Q36230821-0F5BD951-A588-424D-A23B-42E0FE25F06D Q36459134-542EC9C6-9D40-4B6E-AB5C-C65A9A78E045 Q36515384-7C9BA783-8A62-4256-A94E-9652F0B70F16 Q37016116-7DC871A3-C866-47FD-A72B-1FA8781D43C2 Q37020150-927A52DB-E86D-4E1C-BCD3-A2E3A2245113 Q37168763-29B12A67-219A-42EB-A7A3-C67A95B3B486 Q37237180-9CCD1D01-E381-4759-8278-2EC993949530 Q37238147-ECFD1D3B-E442-462E-8710-A7B3D2270883 Q37273894-1824B765-DB3B-4F0E-9DEF-5E94C4758E8C Q37813184-875877B9-19C4-4B5F-AA2E-FD3BF2D7EDFF Q38106504-C5E198D9-B981-4F24-9C8F-D8E1D8B4FA01 Q39066094-CA1C148E-A3B0-4714-BA45-C90DA60F1356 Q39347912-2D59FE1B-E9B4-4BA9-AED1-5B35C3C15E56 Q39373880-18085F35-F48F-4467-B2C1-3F33CB85E520 Q40503693-62353BFC-B77C-46E2-9522-3C2BAB614778 Q41667853-931904BA-F789-420F-832A-DAA63ED8EE26 Q44735545-0FF8527C-0815-453F-B144-6749FE98620B Q45946884-20932FD8-BBB8-47E1-8CBB-F4F546D5CC6D

P2860

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

http://www.wikidata.org/entity/Q34356168

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@ast

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@en

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@nl

type

label

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@ast

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@en

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@nl

prefLabel

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@ast

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@en

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@nl

P1433

Q34356168-A22EF7A3-CE81-4661-8E7E-3DF6C79792CE

P1476

Q34356168-32C4B1D2-B386-43D7-AFC8-B124160EBA0D

P2093

Q34356168-1684EC49-15EB-45BE-9337-8B31AA20CE57

Q34356168-1FD37C80-8F55-440A-852E-96AB6D860F18

Q34356168-2175FDBC-8F05-40B5-8051-C348B179972D

Q34356168-31538701-EBC0-4A8B-9093-EFCEA0B15490

Q34356168-77FFCE8D-434A-462E-ABCC-5D7E4212E6DB

Q34356168-9ECB0DA7-DAA5-4332-88AD-6B6170CAFD9D

Q34356168-C828290C-1F22-49E7-9F12-A7C07E4AD53D

P304

Q34356168-513D63C3-54FA-4550-BB59-F0D1430C6EF7

P31

Q34356168-3901DED4-2ECE-49B2-B265-BECF04907B53

P356

Q34356168-C6A95DB3-28FB-40CB-B1D0-D670E3C9ACDE

P407

Q34356168-3180A148-4D35-4F18-8DBB-3897E68F8FCD

P433

Q34356168-F632C827-DCE4-4688-A56D-D750A1DD6EE2

P478

Q34356168-1E1B60C8-DBCE-43C0-AFF3-1F6B8157D9C8

P50

Q34356168-2650D30E-9BD9-4D29-95AF-0EF44354CE2B

Q34356168-762C51AC-AC11-4940-9C07-6F77E7425ED8

P577

Q34356168-BCA63964-2428-4FC0-BB95-074B037BB39C

P5875

Q34356168-4CBB47EB-92E5-4312-BC31-871794C62654

P698

Q34356168-25C3A788-88A7-443D-97E1-4D10B7D288D7

P921

Q34356168-BDE15A4E-8FB1-4FED-8BD9-6FE2C46A33D5

P356

JAMA.292.13.1581

P1433

Journal of the American Medical Association

P1476

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

@en

P2093

Alex P Reiner

http://www.w3.org/2001/XMLSchema#string

Eric B Larson

http://www.w3.org/2001/XMLSchema#string

Frits R Rosendaal

http://www.w3.org/2001/XMLSchema#string

Nicholas L Smith

http://www.w3.org/2001/XMLSchema#string

Noel S Weiss

http://www.w3.org/2001/XMLSchema#string

Rozenn N Lemaitre

http://www.w3.org/2001/XMLSchema#string

Thomas Lumley

http://www.w3.org/2001/XMLSchema#string

P304

1581-1587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.292.13.1581

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

Susan R Heckbert

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8248719

http://www.w3.org/2001/XMLSchema#string

P698

15467060

http://www.w3.org/2001/XMLSchema#string

P921